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Abstract: The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a public
health emergency that turns the year 2020–2021 into annus horribilis for millions of people across
international boundaries. The interspecies transmission of this zoonotic virus and mutated variants
are aided by exposure dynamics of infected aerosols, fomites and intermediate reservoirs. The
spike in the first, second and third waves of coronavirus confirms that herd immunity is not yet
reached and everyone including livestock is still vulnerable to the infection. Of serious concern are
the communitarian nature of agrarians in the livestock sector, aerogenous spread of the virus and
attendant cytocidal effect in permissive cells following activation of pathogen recognition receptors,
replication cycles, virulent mutations, seasonal spike in infection rates, flurry of reinfections and
excess mortalities that can affect animal welfare and food security. As the capacity to either resist
or be susceptible to infection is influenced by numerous factors, identifying coronavirus-associated
variants and correlating exposure dynamics with viral aerosols, spirometry indices, comorbidities,
susceptible blood types, cellular miRNA binding sites and multisystem inflammatory syndrome
remains a challenge where the lethal zoonotic infections are prevalent in the livestock industry, being
the hub of dairy, fur, meat and egg production. This review provides insights into the complexity
of the disease burden and recommends precision smart-farming models for upscaling biosecurity
measures and adoption of digitalised technologies (robotic drones) powered by multiparametric
sensors and radio modem systems for real-time tracking of infectious strains in the agro-environment
and managing the transition into the new-normal realities in the livestock industry.
Keywords: bioreceptors; endocytosis; exposomics; immunogenetics; precision-farming model;
pyrogenicity
1. Introduction
Coronaviruses (CoVs) are fairly pleomorphic or crown-shaped, single-stranded,
positive-sense RNA viruses from the Coronaviridae family. CoVs are highly pathogenic,
polyadenylated in nature and primarily infect the respiratory tracts of the hosts [1,2]. These
nonsegmented cis-acting viruses have the largest ribonucleic acid genomes (30–32 kb)
with a 5′-cap structure and 3′-poly-A tail [3]. Genotypic and serologic tools group these
viral strains into four subfamilies, namely α-, β-, γ- and δ-CoVs [4]. The recent outbreak
of coronavirus infection is traceable to a cluster of isolates from pneumonia patients in
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the Chinese city of Wuhan in December 2019. Aetiology of the viral strain was con-
firmed to be β-coronavirus sequel to bronchoscopy and sequencing of bronchoalveolar
lavage fluid. Comparative homological analysis shows high (~88%) genetic similarity with
bat-derived severe acute respiratory syndrome (SARS)-like coronavirus (bat-SL-covzc45,
bat-SL-covzxc21) and (~70%) to SARS-CoV-2, respectively [5,6]. Within 6 months, the virus
(SARS-CoV-2) spread to over 213 countries and territories due to its rapid adaptive rate,
high infectivity and autochthonous transmissibility across species. There are over two
hundred million (211,717,079) reported cases of COVID-19 infections worldwide. Of these,
victims include 17,710,881 active cases under mild condition, 109,459 active cases under
serious/critical condition, 189,465,076 closed cases (for recovered/discharged patients)
and 4,431,663 deaths as of 21 August 2021 [7]. Despite the administration of antiviral
medications, systemic antibiotics, immune modulators and oxygen therapy and all draco-
nian containment strategies, the world still stands at crossroads in the fight against this
deadly virus.
Although knowledge about COVID-19 is evolving across the geographic landscape,
there are uncertainties and conjectures on its infectivity, containment and herd immunity.
SARS-CoV-2 has a genome size of 27–34 kb and incubation period of 2–14 days [8,9].
This enveloped virus contains lipid bilayer encoding the genome in spike (S), membrane
(M), nucleocapsid (N), or haemagglutinin-esterase glycoproteins [10,11]. Approximately
80% of COVID-19 infections are asymptomatic or mild; 15% are severe, requiring oxy-
gen; and 5% are critical, requiring ventilation [12]. It is transmissible symptomatically,
asymptomatically or paucisymptomatically by contact with fomites, incubation carriers
and respiratory droplets from persons or animals [13,14]. Oral compulsive habit of nail
biting (onychophagy), reflex action of coughing or sneezing at close range and frequent
touching of face or mouth with infected fingers are possible ways of contracting the virus.
Infected microdroplets and aerosols may spread coronavirus during breathing, coughing or
sneezing as intrafamilial spread is rising locally too. SARS-CoV-2 is transmissible through
nebulising therapy, bronchoscopy, endotracheal intubation, suctioning tracheotomy or
cardiopulmonary resuscitation that yields a high volume of respiratory aerosols [4,15].
1.1. Herbivory and Intricacies of Exposure Dynamics
Viruses can infect any organism in the ecosystem. Earlier scientists found plants to
be the first hosts to viroids or virions [16]. Metagenomic analyses posit that plants can
be latently infected by positive single-stranded RNA viruses with no symptoms but soon
degenerate into acute disease condition [17,18]. Cross-species transmission of SARS-CoV-2
is not an exception where herbivory exists. Abraham (2006) [19] defines herbivory as a form
of feeding by which heterotrophs feed on autotrophs or prey organisms. Herbivory exposes
the nasal cavity, posterior pharynx, trachea, glottis, vocal cords and bronchopulmonary
segments to ecological variables as one of the drivers of land-use dynamics. Herbivores
are multicellular eukaryotic species that are anatomically and physiologically adapted to
feeding on forage and fodder crops. The majority of herbivores belong to Artiodactyla
(even-toed ungulates), Perissodactyla (odd-toes ungulates), Squamata (reptiles) and Tes-
tudines (chelonii) animal orders. Bats, being flying herbivores with unique aerodynamics
capacity, can harbour coronaviruses. The coexistence of herbivores with sessile autotrophs
in loose aggregations, complex groups or colonies creates dynamic interspecific interactions
that may be mutualistic, competitive, facultative or antagonistic in nature [20]. Either by
chewing or piercing–sucking mechanism, herbivorous feeding strategies are diverse and
consist of algaevores (algae-feeders), folivores (leaf-eaters), granivores (seed-eaters), frugi-
vores (fruit-eaters), nectivores (nectar-feeders), sap-feeders (sucking liquid from phloem
or xylem) and leaf–stem–root chewers (Figure 1). The mode of feeding under a resource-
driven system makes herbivores and transhumance pastoralists vulnerable to the vagary
of microbial aerosols and infections. The permeability of the nasal cavity makes it easy for
particulate matter to be filtered and trapped in the cranial fossae of the nasal septum [21].
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Figure 1. Repertoire of polygenic markers influencing sociogenomics and behavioural stereotypes among vertebrates on 
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with cognitive and well-coordinated instincts of sighting and selection to gather food for 
immediate consumption, storage or provisioning. Whilst strains of infectious diseases can 
be trapped by respiratory tracts, integumentary organs or natural orifices, the tonsillar 
crypt epithelium is probably the initial infection site for active viral replication. Certain 
viruses and toxins can be conveyed by axonal transport along peripheral nerves such as 
rabies virus (RABV), pseudorabies virus (PRV), alpha-herpesviruses (herpes simplex 
(HSV-1)), West Nile virus (WNV), poliovirus (PV) and Theiler’s encephalitis virus 
(TMEV). Exposing the conjunctiva, mucosae (nasal or larynx) and alveolar capillary net-
work of livestock or humans to disease-carrying droplets or aerosols will affect the func-
tionality of body systems. To ensure the welfare of free-grazing stocks and personnel in 
the agricultural sectors, omics-enabled tools can be optimised for sensing viral loads and 
Figure 1. Repertoire of polygenic markers influencing sociogenomics and behavioural stereotypes among vertebrates on
pasture land.
By virtue of their adventurous habit, herbivores use visual and olfactory receptors
with cognitive and well-c ordinated instincts of sighting and selection to gather food for
immediate consumption, storage or provisioning. Whilst strains of infectious diseases can
be trapped by respiratory tracts, integumentary organs or natural orifices, the tonsillar
crypt epithelium is probably the initial infection site for active viral replication. Certain
viruses and toxins can be conveyed by axonal transport along peripheral nerves such
as rabies virus (RABV), pseudorabies virus (PRV), alpha-herpesviruses (herpes simplex
(HSV-1)), est Nile virus (WNV), poliovirus (PV) and Theiler’s encephalitis virus (TMEV).
Exposing the conjunctiva, mucosae (nasal or larynx) and alveolar capillary network of
livestock or humans to disease-carrying droplets or aerosols will affect the functionality of
body systems. To ensure the welfare of free-grazing stocks and personnel in the agricultural
sectors, omics-enabled tools can be optimised for sensing viral loads and make accurate
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theranostic predictions. Exposomics is considered a suitable option for determining the
totality of nongenetic exposure dynamics and effect on system function, which is ideal
for robust characterisation and validation. Thus, using robots or drones powered by
biosensors and radio modem systems for viral tracking and evaluating the putative effect
of exposure milieu on livestock and farmers might safeguard the livestock industry from
the devastating effect of SARS-CoV-2 and its mutant variants.
1.2. Justification for the Review
Of pertinent concern is the severe impact of time-varying exposure of livestock
(raised for milk, egg, meat, fur, hide and skin) and personnel involved in the food chain
to the highly infectious SARS-CoV-2. The prevalence of RNA viruses in the environ-
ment is worrisome with 89% of viral species (160) being zoonotic and having a high
case fatality rate [22,23]. CoVs are causative organisms of lethal zoonotic infections in
avian, bovine, canine, feline, ovine and porcine species [24]. For instance, mammals
and bats harbour α- and β-CoVs, mammals and avian species are often infected by
γ-CoVs and birds and mammals are often infected by δ-CoVs [25]. Symptoms of severe
acute respiratory syndrome (SARS) affirm that CoVs may quiescently surface from
animal reservoirs and potentially elicit mild to severe respiratory disorder or septic
shock in humans [24–27]. Episodic exposure during routine and periodic activities in
the agro-environment can raise susceptibility to putative agents of disease infection.
Unlike among humans, social distancing, face-masking and sneezing on elbow joints as
means of self-protection are not practicable amidst free-ranging chickens, ruminants,
bats, mink or pets due to the complexity of speciation, sociality rhythms and inter-
connectedness of stereotypic behavioural instincts (Figure 1). Nomadic farmers, who
might not be able to afford mobile and suitable personal protection kits with adequate
filtering efficiency to intercept viral particles on the farm, are also at risk. The spread of
this virus in the agricultural sectors is worth serious consideration vis-a-vis the involve-
ment of humans in food security and undue exposure to aerosols in the environment
(Figure 2). Research on viral syndrome in agricultural sectors mostly adopts a reduc-
tionist approach by studying one or two stressors at a time under controlled laboratory
conditions. The status quo is further worsened by the limitation of conventional ap-
proaches in producing a holistic approach of curtailing the problem of infectious diseases
in the livestock industry. While it is ineffective to use a one-size-fits-all approach for
addressing the multiplicity of factors linked with exposure dynamics in a lifetime, the
cumulative effect of livestock and farmers’ exposure to coronavirus and its variants is
life-threatening. Therefore, the aim of this review is to give insight into SARS-CoV-2 and
propose the use of catch-all, smart-farming precision models and biosensor-powered
digital technologies (robotic drones) for rapid-response and high-throughput screening
of livestock, farmers, paddocks, poultry pens and agro-environment against coronavirus
infection (Figure 3).
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Figure 2. Some spirometric indices affected by xposure to inhalable viral aerosols and microdroplets during routine or
periodic activities. Key: TV: Amount of inhaled and exhaled air during a normal respiratory cycle in the lung. MRV: Amount
of tidal air passing in and out of the lung per minute. ERV: Amount of air that can be expired beyond the tidal volume.
RRV: Tidal volume + expiratory reserve volume; obtained by taking a deep breath (maximal breathing) and exhaling all
the air from the lung or VC = by adding IRV + TV + ERV. FEVT: Timed vital capacity, which determines impairment of
pulmonary function or mechanical condition of the lung, e.g., dyspnea (shortness of breath), asthma and emphysema. IC:
Measures maximum voluntary ventilation or IC = IRV + TV or VC-ERV. IRV: Amount of gas that can be inhaled after normal
inhalation, filling the lungs with tidal air. RV: Amount of air left after expiratory reserve volu e that cannot be forcibly
expelled. MIC: Measures glossopharyngeal breathing (air stacking) or maximum volume of gas that can be held within
closed glottis.
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2. Comorbidity of Coronavirus Infections across Species
Viruses are obligate intracellular parasites having ribonucleic acid (RNA) or deoxyri-
bonucleic acid (DNA) with single or double strands enclosed within a protective protein
shell (capsid). The capsid has oligomeric structural subunits constructed with helical,
icos hedral or com lex symmetry. It shields the genome from lethal agents. Viruses are
acellular, lacking enzy e machinery for metabolism and ribosome for protein synthesis,
but carry their own genome during transmission [26]. They depend on host cells for repli-
cation, genome transcription and translation of mRNA transcripts into proteins. Viruses
are enveloped, filamentous, isometric (icosahedral) or head–tail shaped. RNA viruses
are less stable than DNA viruses [25]. Both have divergent genome sizes of diameter
20–400 nm. Using genomic sense or polarity system, RNA viruses belong to two groups:
positive-strand and negative-strand viruses [26]. Most ssRNA viruses have ∼6–14 positive
charges on sequence adjacent o the interior of the capsid at the amino or C-terminal
ends. CoVs are envelope RNA viruses and have been a major public health emergency
for decades. Approximately 70% of viruses are ribonucleic acid (RNA) viruses and are
responsible for almost 44% of emerging infectious diseases under various ecological zones
worldwide. Incidence of lethality has remained high since 1931 when the first human
coronavirus (HCoV-229E) was discovered, and enteric CoV was isolated from turkeys in
1951 [26]. The novel coronavirus (SARS-CoV-2) exhibits bulbar projections produced from
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the spike of glycoprotein (peplomers) on the capsid. Its zoonotic nature implies that both
humans and animals are vulnerable to infection. The susceptibility of nonhuman species
has been confirmed by sequencing oral and nasopharyngeal swab specimens from Syrian
hamsters, bats, cats, dogs, ferrets, lions, mink and a few companion animals. Analysis
of samples from the upper respiratory tract of ferrets equally confirms the prevalence of
SARS-CoV-2 infection, but weak replication of the same strain was found in chickens, dogs,
ducks and pigs. However, the high nucleotide similarity index (96.2%) of SARS-CoV-2
with coronavirus RaTG13 shows that horseshoe bats (Rhinolophus spp.) harbour the same
viral strain [26–28].
Aside from COVID-19, Ebola, severe acute respiratory syndrome (SARS) and Middle
East respiratory syndrome (MERS) are common RNA viral diseases that confer burdens of
illnesses across species [5]. Complications emanating from such infections are heteroge-
neous across gender and age groups but correlate with morbidity indices. Comorbidity is
the coexistence of one or more diseases simultaneously with a primary medical condition in
a patient. Most patients that died of COVID-19 had comorbid complications that worsened
their chances of survival. While elderly people with underlying conditions are prone to
higher risks, children infected with the virus manifest mild or no symptoms. The majority
of patients in intensive care units or under invasive mechanical ventilation exhibiting a
high prevalence of comorbidities (46–86.2%) due to extreme obesity (BMI ≥ 30), chronic
renal failure, asthma, hypertension, type 2 diabetes, ischemic heart disease and chronic
obstructive pulmonary disease did not survive [29]. General feeling of malaise, fever,
dry cough, anorexia, pneumonia, abnormal heartbeats, shortness of breath, lymphopenia
and high viral loads linked with cytokine activation and histopathological changes are
concomitantly detected during clinical tests [30]. Loss of smell or taste and acute confu-
sional state (delirium) coupled with disorientation, psychomotor changes and clouding
of consciousness are newly detected COVID-19 symptoms. Recent findings affirm that
patients suffering from severe SARS-CoV-2 infection have elevated levels of C-reactive
protein, ferritin and D-dimer; high neutrophil-to-lymphocyte ratio; and increased levels of
inflammatory cytokines and chemokines [31]. The overlapping effects of these conditions
impact comorbidity–polypharmacy score, cumulative illness rating and mortality. Many
people and livestock animals are still vulnerable to coronavirus infection. To ensure animal
welfare and efficient biosecurity measures in the agro-environment, it is necessary to use
novel biosensors for viral detection, tracking immune response and identifying high-risk
zones to minimise exposure to viral aerosol and microdroplets from humans, livestock,
fomites or passive vectors.
2.1. Pyrogenicity and Vital Signs of COVID-19 Infection
Aside from underlying health conditions, “vital signs” are routinely used by healthcare
providers to ascertain the composite endpoint of patients with mild to critical illness. Body
temperature, respiratory rate, pulse rate and blood pressure are common vital signs of
infection [32,33]. From recent findings, about 44–98% of COVID-19 patients rank high
for pyrogenicity scoring. This fever-inducing condition is caused by febrile response to
endotoxin infection, inflammation or trauma [34,35]. Commonly known as fever, pyrexia
is a syndrome characterised by alteration in immune response and abnormal elevation
of body temperature beyond a thermal set point or balance point. All mammals can
experience continuous, remittent, septic, relapsing, cyclical recurrent or periodic forms of
fever. Rectal, axillary, oral, tympanic or temporal artery temperatures exceeding 37.2 ◦C
are symptomatic of fever in adults and children. Temperatures for severe and extreme
hyperpyrexias are ≥40 and ≥42 ◦C, respectively. Pyrogens are fever-inducing substances,
and fever onset involves simultaneous inhibition of heat loss and in vivo stimulation of
heat. The fever induction process is either endogenous or exogenous in nature. While
endogenous pyrogens activate cytokines in the host, the exogenous pyrogens use microbial
endotoxins externally to initiate febrile response. Exogenous factors influence innate
immune pathways to induce endogenous expression of pyrogenic cytokines (IL1α, IL1β,
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IL6, TNFα, TNFβ, IFNα, INFβ and INFγ) and body temperature [36,37]. The pathway is
mediated by phospholipase-A2, cyclooxygenase-2 and prostaglandin-E2 synthase enzymes
to modulate heat generation and vasoconstriction. Endogenous pyrogens are transmitted to
the hypothalamic thermoregulatory axis, mainly organum vasculosum of lamina terminalis
where synthesis of PGE-2 starts [38]. A pyrogen test is preliminarily used to assess the
body temperature of anyone suspected to have contracted SARS-CoV-2. Response to
pyrogenic substance is further validated by determining interleukin-1β (IL-1β) production
using enzyme-linked immunosorbent assay. These tests can also be adopted by farmers to
determine the state of wellness of their flocks.
2.2. Endocytosis of Coronaviruses
Endocytosis is a cellular mechanism of sequestrating molecules (electrolytes, ligands,
proteins or pathogens) into membrane vesicles or vacuoles, a process that occurs at varying
molecular weights [39]. Viruses gain access to the host cell through receptor endocytotic
migration and complete the life cycles through the cytoplasm [40]. They have three
endocytotic mechanisms: phagocytosis, pinocytosis and receptor-mediated endocytosis
or clathrin-mediated endocytosis for infecting new hosts. Cell invasion by coronaviruses
involves receptor binding and membrane fusion to induce viral tropism or pathogenicity.
Endocytic entry occurs in a stepwise manner by receptor clustering, activating signalling
pathways, forming endocytic vesicles, cargo delivery to endosomal compartments and
sorting into cytosol [25]. When a virion infects a host, its nucleic acid is released from the
capsid into the host cell, where it seizes the endocytotic pathway and uses host machinery
for replication until it cannot carry out its normal functions [39,40]. Penton bases attach to
hexons to prompt structural viral entry and fusion with arginylglycylaspartic acid peptide
motif to ensure adhesion to the extracellular matrix. After attachment, the viral genome
translates and synthesises precursor polyproteins (pp1a and pp1b) processed by ORF1a
encoded by papain-like proteinase (PLpro) and 3C-like proteinase (3CLpro) into 16 mature
nonstructural proteins (nsp1-nsp16) [13,26]. RNA viruses such as SARS-CoV-2 are capable
of colonising different species, masking nucleic acid structures and sequestrating signalling
cascades to exert cytopathogenic or neuroinvasive effects. Infectivity and virulence factors
are key influencers of pathogenicity. As infectivity deals with microbial capacity to initiate
infection and colonise the host, virulence weakens the host’s fitness by causing damage
subsequent to attachment, immunoevasion, transcription, genome replication, translation,
assembly and release of virions.
Most coronaviruses have host-specific accessory proteins of 50–300 amino acids with
gene products in the 3’-proximal genome regions coding for virulence factors [41]. A
number of candidate genes code for disease pathogenesis and innate immune response.
Cluster of differentiation-209 (CD-209), angiotensin-converting enzyme-2 (ACE-2), C-
type lectin domain-4 (CLEC-4 or L-SIGN), mannose-binding lectin (MBL-2), interferon-α
and -β receptor-2 (IFNAR-2), tumour necrosis factor alpha (TNF-α), 2’-5’-oligoadenylate
synthetase-1 (OAS-1), Fc fragment of IgE receptor-2 (FCER-2) and Toll-like receptor-4
(TLR-4) are among common candidate genes associated with CoV phenotypes. While
viral strains exquisitely bind to receptor molecules to initiate infection, the availability
of receptors coding for species specificity enhances viral infectivity [42]. The severity of
viral-induced infection depends on the underlying condition of the host, cellular receptors,
transcription factors and immune responsiveness [43]. It should be recalled that transcrip-
tion factors are proteins binding to promoter and enhancer sequences for controlling gene
expression. Sensing viral products leads to activation of a signalling cascade for transcrip-
tional activation of type I and III interferons with other antiviral genes mediating viral
clearance and inhibiting its spread. High risk factors accompanying respiratory viruses
often affect the integumentary and pulmonary functions via direct contact with infections
in the environment (Figure 2).
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3. Viral and Host Receptor Interaction
Cellular receptors of human coronaviruses (HCoVs) belong to the membranous ec-
topeptidase family [4,22]. Receptors are macromolecules (glycoproteins) mediating bio-
logical processes to bind signaling molecules (ligands) intracellularly or extracellularly for
initiating cellular responses. Intracellular receptors exist within the cytoplasm and bind to
hydrophobic ligands roving across the plasma membrane. Cell-surface receptors (trans-
membrane receptors) are membrane-anchored proteins that bind to ligands on the surface
of the cell to perform signal transduction functions [4,13]. Receptors have a transmembrane
domain and an extracellular domain with a ligand binding (allosteric binding) site. The
binding of receptors to ligands occurs at agonistic (ligand-binding) and antagonistic (ligand-
blocking) sites. These include ligand-gated channels, G-protein-coupled receptors and
enzyme-associated receptors. An enzyme-linked receptor is an integral membrane protein
performing catalytic and receptor functions. Receptors undergo conformational changes to
elicit responses by actively binding to or dissociating from ligands in cellular signaling or
gated ion channels. Ligand-gated ion channels or ionotropic receptors are transmembrane
ion-channel proteins that open to allow passage of Na+ K+, Ca2+ and/or Cl− ions through
the membrane in response to the binding neurotransmitter. G-protein-coupled receptors
such as 7T-transmembrane domain receptors, heptahelical receptors, serpentine receptors
and G-protein-linked receptors detect molecules extracellularly and activate internal signal
transduction pathways and cellular responses [44].
Viruses use multiple molecular species as receptors for infecting target cells. These re-
ceptors consist of sialic acid (C11H19NO9), glycosaminoglycans (negatively charged polysac-
charides) and cellular adhesion molecules (intercellular adhesion molecules, vascular cell
adhesion molecule-1), acetylcholine receptors, chimeric antigen receptors, interleukin-2
(IL-2) receptors, complementary receptors, growth factor receptors and neurotransmitter
receptors [45–47]. Genome encoding occurs after viral invasion to elicit gene expression,
accessory proteins and adaptation to the host. SL-CoV and SARS-CoV share similar ge-
nomic sequences and highly conserved gene products in the receptor-binding domain of
the N-terminal region of S-proteins. A virus is unlikely to establish and replicate itself in
the host without evasion or antagonism. As the mechanisms of attachment, intracellular
trafficking, uptake and incursion into cytosol are affected by the bond between virus and
receptor, the synergy between them even heightens the probability of infection occurring
and activity of spike protein in the process. Whilst host cells exert defense mechanisms
for rapid detection of infection or suppression of immune response, viruses have ways
of evading them through pattern recognition receptors (PRRs). Upon infection, PRRs
sense nucleic acids in the cytoplasm or nucleus to activate antiviral innate immunity. RNA
viruses use non-primer-dependent mechanisms for replication, distortion of RNA recogni-
tion and antiviral signaling. SARS-CoV-2 exploits the angiotensin-converting enzyme-2
(ACE-2) and cellular protease TMPRSS2 receptors to penetrate the host through the ACE-2
pathway [46]. ACE-2 is a zinc metalloenzyme and transmembrane receptor expressed in
the glandular cells of gastric, duodenal and rectal epithelium; pneumocytes of the lungs;
enterocytes of the small intestine, heart, kidney, liver and testis; and vascular endothelium
cells. ACE-2 serves as an entry point into cells for HCoV-NL63, SARS-CoV and SARS-CoV-
2. It coincidentally acts as a receptor for severe acute respiratory syndrome. The density of
ACE-2 in each tissue correlates with severity of disease [45,47].
3.1. Viral Tropism and Immunogenicity of Coronaviruses
By definition, viral tropism is the capacity of viral strains or isolates to cause infection
in cells or tissues and induce syncytial formation as acute or chronic infections [48]. Acting
as a macrophage (M), T cell or dual tropic, tropism is a major factor in pathogenesis and
persistence of infection in the peripheral motor nerves and central nervous system. Viral
tropism develops in stages in a receptor-dependent or receptor-independent manner. All
the developmental stages culminate with the synthesis of progenies [46]. Replication
of RNA viruses within the host cell depends on enzymes in the virion to synthesise its
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mRNA. Viral RNA also serves as its own mRNA. Most RNA viruses complete their repli-
cation in the cytoplasm, while others are transcribed in the nucleus. Several infectious
pathogens go through causative and reactive pathways to reach their targets. As viral titres
are highest at the early stage of infection, the viral kinetics varies between symptomatic,
asymptomatic and paucisymptomatic among patients [49]; a virion with glycoprotein
(GPX) enters the host and then targets the cell with GPX receptors and fuses with it to
initiate reverse transcription and synthesis of viral proteins plus ribonucleic acid followed
by an assemblage of viral particles to advance its tropism. Pathogenesis of coronaviruses
conforms to either intestinal or respiratory infection model. Almost 80% of COVID-19
symptomatic patients develop mild conditions; 15% develop severe hypoxaemia, dysp-
noea and tachypnoea conditions; and 5% become critically ill with septic shock and/or
multiorgan dysfunction [50].
Another pertinent issue is the immunogenicity of coronaviruses. Coronaviruses en-
code accessory proteins likely involved in immune antagonism or pathogenesis. Immuno-
genicity is the capacity of foreign substances (antigens) to induce humoral or cell-mediated
immune response in the host. Innate immune response acts as the first line of defence
against pathogenic agents by detecting pathogen-associated molecular patterns [51]. Res-
piratory viruses thrive in a condition where the immune system is either depressed or
underdeveloped. There is a wide variation in terms of immune response elicited by dif-
ferent viral strains. Whilst every cell has an intrinsic capacity to restrict viral infection,
most respiratory viruses can suppress innate immune responses to efficiently replicate and
induce it [42]. When the immune system is infected by pathogens, it concentrates in the
epitopes, which allow host cells to differentiate between closely related foreign invaders.
The early stage of innate response is critical in shaping the downregulation of the adaptive
immune response. While some victims develop lifetime immunity against certain viral
infections, others are extremely susceptible. For instance, the likelihood of reinfection
of a person who has previously suffered from chicken pox is low, but reinfection with
haemagglutinin-neuraminidase (H1N1) flu strain might occur after 10 years. Again, infants
and adolescents who have recovered from mild COVID-19 infection soon become criti-
cally ill by reason of exaggerated immune response, known as multisystem inflammatory
syndrome in children (MIS-C) [51–53].
As shown in Tables 1 and 2, some nonhuman outbreaks such as bovine coronavirus
(BCoV) from cattle, infectious bronchitis virus (IBV) from chickens, porcine respiratory
coronavirus (PRCoV) plus porcine haemagglutinating encephalitis virus (PHEV) from
pigs, feline coronavirus (FCoV) from cats, canine respiratory coronavirus (CRCoV) from
carnivores and bat-SL-covzc45/bat-SL-covzxc21 from bats exhibit respiratory tropism
with varying complications or outcomes [26,54]. The chain of infection across species
suggests that foraging animals and nomadic farmers in an agrarian environment are
vulnerable to COVID-19 infection. In response to viral infection, most cell types produce
interferons for release into extracellular fluid in the host. Interferons (IFN) are naturally
occurring glycoproteins from the helical cytokine family. IFNs have molecular weights of
16,776–22,093 dalton. Interferon is obtainable from leukocytes (IFN-α), fibroblasts (IFN-β)
or lymphocytes (IFN-γ) of human cells. The IFN system is a major frontline defence against
viral infection. IFNs are type I (IFNα and IFNβ) and type III (IFNλ) cytokines. They
are secreted in response to viral infections and biological inductions. Early control of
viral replication by type I interferons, complement proteins and innate immune mediators
limits the spread of viruses in the early phase of infection. Expression of IFN genes
occurs downstream of the double-stranded RNA-sensing by host RIG-I-like receptors for
coronavirus infection.
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Table 1. Characterisation of genome and natural reservoirs of coronaviruses among avian species.
Host Species Phylogenetic Genera ofCoronaviridae Family
Designation of Viral
Isolate/Prototype Implication of Infection






Infectious bronchitis virus (IBV)
strain; chicken-dominant
coronavirus (CdCoV).
Replication of virions in the epithelial
layers weaken the immune response,
causes nutrient malabsorption,






Infectious bronchitis virus (IBV),
DdCoV/GD/2014
Fatal, rapidly spreading viral infection
of young ducklings.






infectious bronchitis virus (IBV)
Precociously infected geese exhibit
respirotropism, retarded growth,














Distortion of respiratory tract and
renal blot, nephritis, visceral gout, air
sacculitis, conjunctivitis, sinusitis,
splenomegaly, poor hatchability, excess
mortality.





Ruffled feathers, dyspnoea and
excessive mucus from the beak, high








syndrome, enteritis, low feed intake,






Bluecomb (enteric) disease and
diarrhoea, poult enteritis complex or
intestinal disorders at starter phase,
anorexia, emaciation,
morbidity/mortality (5–100%), poor
egg quality (shell deformation,
albumen thinning).
Table 2. Characterisation of natural reservoirs of coronaviruses among selected mammalian species.
Host Species Phylogenetic Generaof Coronaviridae
Designation of Viral












Diminishing bat genetic conservation.
Reducing annual crop pollination,









Severe diarrhoea in neonate calves,
winter dysentery in cattle, respiratory
infections in calves. Silvopastoral
grazing/ranching restriction, tacit
weight loss, morbidity, emergency
culling, low meat and milk yield.
Dromedary Camel Camel coronavirus(α-coronavirus)
DcCoV UAE-HKU23;
MERS-like CoV
Source of zoonotic Middle East
respiratory syndrome (MERS-CoV)
infecting unciliated bronchial






Feline infectious peritonitis (FIP),




seroconversion among cats. Biotypes
replicate in macrophages, causing
severe and lethal disease.




Weight loss, malabsorption of
nutrients and water due to diarrhoea,
decline in tourism and economic
outcomes for hospitality industry.
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Table 2. Cont.
Host Species Phylogenetic Generaof Coronaviridae
Designation of Viral








Induces acute respiratory distress
syndrome, cytokine storm and
multiple complications in
immunocompetent adults and infants.




Mink coronavirus WD1127, WD1133, MV1-Lu, NB3SARS-CoV-2, NB7 SARS-CoV-2











Receptor (CEACAM1) binds MHV
S-protein to activate virus–cell
membrane fusion A59 strain. It infects
mice liver and brain, demyelinating













Infects ciliated bronchial epithelial
cells and type II pneumocytes causing
swine acute diarrhoea syndrome






Infects upper respiratory tract,
sparing the lungs. Shortage of wool,
meat, gourmet products.
By interacting with their specific heterodimeric receptors on the cell surface, inter-
ferons initiate an array of signals that induce cellular antiviral activities, modulate in-
flammatory responses, inhibit or stimulate cell growth and apoptosis and modulate other
components of immune system [52]. Stimulation of interferon (IFN)-dependent antiviral
response at the early stage of infection is vital for monitoring immune response. Host
sensing of viral double-stranded RNA triggers the activity of IFNs [55]. IFNs initiate innate
immune responses by exerting direct antiviral effects on interferon-stimulated genes [56].
IFN invasive strategies involve avoidance, suppression of IFN induction and signaling. By
avoidance, a virus masks itself or by-products from being recognised by the host sensors
that activate the IFN system. Viruses can suppress IFN induction by inhibiting sensors in
the host or downstream signaling molecules to prevent initiation. By suppressive means,
gene products in the viral gene block signaling events or downregulation of type I IFN
receptors to inhibit the activation of an antiviral state in the infected cell or enhancement of
IFN response by activating late type I IFN genes [57].
Of five groups of immunoglobulins (IgG, IgA, IgM, IgD and IgE) with diverse amino
acid sequences, antibodies exist in soluble and membrane-bound forms. Antibodies and
antigens interact by spatial complementarity of lock-and-key mechanism. High specificity
and affinity is the most striking feature of antigen–antibody interaction. Antibodies are
secreted by β-cells in the adaptive immune system or plasma cells. Each antibody unit
has a minimum of two antigen-binding sites bound bivalently or multivalently. Bonding
of an antibody with an antigen forms an immune complex functioning as an entity. The
immune system releases protein messengers for regulating the immune defence of host cells.
The collective term for these messengers is cytokines. Cytokines are glycoproteins acting
nonenzymatically on target cells of picomolar to nanomolar concentrations. The physiology
of cytokines is complex and diverse. Cytokine secretion can stimulate the release of different
cytokines to express the same functions [58]. It mediates the actions of interleukins,
interferons and tumour necrosis and growth factors. The majority are secreted by more
than one type of immune system, fibroblasts and endothelial cells. Cytokine interleukin-2
influences the function of virtually every cell in the immune system. Over-secretion of
immune cells may trigger cytokine release syndrome or cytokine storm [59]. Under multiple
respiratory viral infections, cytokine storm causes virus-induced tissue destruction, extreme
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inflammation and mortality. Several complications at the advanced stages of severe COVID-
19 infection have been linked to cytokine release syndrome. Evidence has shown that the
immune response of COVID-19 patients under critical condition may be as vicious as the
virus responsible for the illness due to comorbidities and hyperinflammatory immune
response [60].
Typically, the capacity of the body to either resist infection or be susceptible is in-
fluenced by a number of factors such as comorbidities, blood type, nutrient cycling and
intactness of immune system coupled with a repertoire of polygenic makers influencing
sociogenomics and behavioural stereotypes across species (Figure 1). Most of the elderly
people that died of COVID-19 infection had underlying conditions and, presumably, short-
ened telomeres [61]. Rapid immune response occurring in the infected host during acute
viral infection indicates the effect of telomere shortening on immune depression. Symp-
toms of telomere syndromes vary but depend on the patient’s telomere length. While some
patients have few or no symptoms, others exhibit bone marrow failure; pulmonary fibrosis;
liver cirrhosis; and gastrointestinal, skin and mucosal abnormalities. Again, it is not clear if
the body of victims can synthesise inhibitory antibodies against viral epitopes and establish
antigen-binding sites against SARS-CoV-2 molecules. As cases of reinfection with SARS-
CoV-2 and its mutant variants are emerging, novel biosensors with robust sero-surveillance
strategy can be exploited as a requisite standard for identifying group risks, estimating
antibody levels and trends of population immunity and predicting response to outbreaks.
3.2. Evolution and Mutability of SARS-CoV-2
RNA viruses have short generation times and fast evolutionary rates. The fastest
evolution corresponds to single-stranded RNA and reverse-transcribing viruses, followed
by double-stranded RNA and single-stranded DNA viruses, whereas double-stranded
DNA viruses evolve more slowly on average. Viral evolutions are mostly identified
from open reading frames. A reading frame is a set of nonoverlapping triplets of three
consecutive nucleotides. An open reading frame (ORF) is a section of the reading frame
with no stop codon which is a sequence of three adjacent DNA or RNA nucleotides
corresponding with amino acid during protein synthesis [62]. It should be noted that
proteins cannot be synthesised if RNA transcription stops before reaching the stop codon.
A gene encoding a protein has an ORF that can be translated into an amino acid sequence
(AAS). To start with, the AAS or nucleotide sequence (NTS) must be obtained from the
same DNA sequence. Since the AAS is the final product under evolutionary trend, multiple
alignments of protein-coding genes use AAS during alignment with NTS. Coronaviruses
contain specific genes in the ORF downstream regions that encode proteins for replication,
nucleocapsid and spike formation. These viruses have overlapping ORFs (ORF1a, ORF1b)
which are a continuous stretch of codons for gene prediction to identify regions of genomic
DNA encoding protein, RNA genes and regulatory regions. The ORF7a gene creates
an accessory protein for viral infection and replication in the host. If the domain of the
ORF is known, the rates of mutation can be modified as wobble base pairing can permit
higher mutation rates in the third nucleotide of a given codon without affecting the genetic
code [63].
Genomes in RNA viruses have the highest mutation rates to circumvent the immune
system of the hosts [64]. This is premised against the circulation of mutant spectra and
replication by viral quasispecies. A minor alteration in NTS or AAS can annul the activity
of a receptor due to errors during replication, deletion or insertion of DNA segments. The
term mutation rate (MR) refers to the frequency of new variants created per site per genome
replication or average number of errors produced in genomes of progeny per base per
replication cycle (mut/nuc/rep) [63–65]. MR is affected by base composition, environment,
size of gene and position in the genome. RNA viruses use encoded RNA-dependent RNA
polymerase for genome replication to exploit mutation and escape antibody and cytotoxic
T lymphocyte responses. The mutation rate is a critical parameter for understanding viral
evolution [66]. Mutations might be induced via random errors during replication or genetic
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shuffling (recombination) among an infected population with weaker immunity. Mutation
influencing spike protein alters amino acid (614) by substitution from aspartic acid (D) to
glycine (G) at a genome domain encoding the spike protein (D614G). MR of RNA viruses
occurs at rates of six orders of magnitude above that of the hosts. Mutability boosts the
adaptation of RNA viruses to varied environments. MR can be calculated as follows:
µ = [(r2/N2) − (r1/N1)] × ln (N2/N1) = (f1 − f2) × ln (N2/N1)], (1)
where r1 = observed number of mutants at time point 1; r2 = observed number of mutants
at the next time point; and N1 and N2 = numbers of cells at time points 1 and 2, respectively.
4. Exposure Dynamics and Organ Functionality
Another caveat of importance is the effect of exposure to inhalable viral aerosols or
microdroplets on lung capacity and functionality of body organs during routine or periodic
activities on-farm and along the food production supply chain in the livestock industry.
This scenario is presented in Figure 2. Aerosol originates from natural or anthropogenic
sources and traverses the stratospheric and tropospheric layers of the atmosphere. Being
a complex mixture of suspended particulate matter, aerosol varies in chemical composi-
tion, microphysical transformation, particle size (0.002–100 µm) and surface-to-volume
ratio [67]. Natural aerosols consist of forest exudates, microbial spores, water droplets,
geyser steam, sea salt, fog, mist, dust or pollen. Mining dust, vehicular smoke, ashes and
smoke are typical aerosols from anthropogenic sources, with a litre of air containing nearly
109 particles [68]. Aerosols can spread from host cells to the adjoining environment through
primary and secondary processes of aerosolisation. With varying aerodynamic diameters
of >5–10 µm for respiratory droplets or <5 µm for nuclei droplets, aerosols can transmit
infectious viruses via nasal cavity, oronasopharynx or mucus membranes. Although coales-
cence of aerosols promotes uniform (monodispersity) or nonuniform (polydispersity) size
distribution, the in vivo deposition of aerosols is largely influenced by the morphology
of the respiratory tract and the mode and pattern of respiration. Inhalable fractions of
aerosol particles can pass through the tracheobronchial and nasopharyngeal airways with
an effective diameter of ≤2.5 µm for permeation to the lungs and ≤10 µm for permeation
to cilia before reaching the alveoli. Pulmonary diseases occur when air flow is obstructed
due to infection, inflammation or mucus accumulation [69]. The combined effect of natural
or anthropogenic activities presents a congenial environment for accumulating aerosols
where livestock husbandry takes place.
Characteristically, coronaviruses can infect linings of the airways, throat, lungs and
blood vessels to elicit cytocidal effects that culminate in the malfunctioning of multiple
organs. The virus can stay infective in aerosols for 3 h and on surfaces for 72 h under
laboratory conditions and 3–8 h postaerosolisation [70,71]. In the livestock industry, a
seasonal spike in the transmission of single-stranded RNA viruses of animal origin from
the Picornaviridae family occur in polygastric kraals, piggery units and poultry farms where
virus-laden airborne particles are harboured in their natural reservoirs. With sketchy
evidence that respiratory coronaviruses peak mostly in winter, there are still claims of their
circulation year-round at lower frequency. Aerosols and infectious agents enhance the
seasonal spread of human strains of coronaviruses (NL63, OC43, 229E or HKU1) causing
common cold in immunocompetent persons [71,72]. Ambient temperature, relative hu-
midity, pH and ultraviolet radiation affect their viability in aerosols and droplets. While
most viruses survive best under low (≤40%) and high (≥90%) relative humidity, coron-
aviruses survive for shorter periods under higher temperatures and relative humidity than
in cooler or dryer environments [72]. High concentrations of ultrafine aerosol particles
(<100 nm) promote viral transmission; comorbidities; and unwanted clinical outcomes in
form of acute myocardial injury, cardiovascular damage, low lymphocytes and abnormal
clotting and renal function due to complications at early and advanced stages of COVID-19
infection [71,72]. Although case studies are scare, there is a high probability of livestock
and nomadic farmers contracting the virus due to routine exposure to infected aerosols,
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droplets or fomites on pasturelands which can distort the mechanical properties of the
pulmonary system by permeating the epithelia layer and replicating the genome to foster
viral viability and infectivity. So, using appropriate farming models and biocompatible
sensors for screening livestock farms and agro-processing units will boost productivity,
ensure biosecurity measures and save the livestock industry from serious fatality.
4.1. Blood Types and Susceptibility to Coronavirus Variants
With high transmissibility from natural reservoirs or fomites eliciting tissue tropism in
permissive hosts, the burgeoning spike in the first, second and third waves of coronavirus
indicates that herd immunity is not yet attained in many countries and humans and live-
stock are still vulnerable to the infection. The unevenness in the pathogenicity index of the
virus implies that some groups are more susceptible than others due to complex interaction
with innate or environmental factors influencing viral susceptibility. A number of anthro-
pogenic activities including exposure to infected pasture, feeds, water or fomites during
livestock grazing, wildlife poaching and preslaughter handling are transmission routes to
permissive hosts. Forni et al. [73] posits that wildlife and domestic animals are intermediate
hosts for human coronaviruses such as severe acute respiratory syndrome (SARS-CoV),
Middle East respiratory syndrome coronavirus (MERS-CoV), human coronavirus NL63
(HCoV-NL63) and human coronavirus 229E (HCoV-229E).
RNA viruses from animal origins are known to mutate more rapidly at the highest
frequency. New cases of mutated SARS-CoV-2 variants have been identified based on
isolates from newly sequenced viral genomes from COVID-19 patients. While some of the
mutations are neutral, others are more contagious and of strong biological significance
in the receptor-binding domain (RBD). These variants include H69/V70, 501.V2, P681H,
E484K and D614G (Table 3). The H69/V70 or SARS-CoV-2 VUI 202012/01 is the “Variant
Under Investigation, year 2020, month 12, variant 01”. It is otherwise referred to as S:
N501Y to prove that it is in the spike glycoprotein of SARS-CoV-2 strains. The 501.V2
variant was isolated in South Africa while tracking the phylogenetics of the SARS-CoV-2
as one that alters the receptor-binding domain of the virus and carries other mutations,
including a double deletion (positions 69 and 70). The D614G variant emerges from an
ancestral D residue found in the glycosylated region of the viral spike protein or RBD of the
spike protein of SARS-CoV-2. These strains are defined by multiple spike protein mutations
(deletion 69–70, deletion 144, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H) with
an estimated potential to increase the reproductive number (R) to≥ 0.4 and transmissibility
to the high level of 70% (ECDC/WHO, 2020). Activities of these variants are attributed
to the presence of 14 mutations leading to three deletions and alteration of amino acid
sequence or RNA viral pathogenesis. Phylogenetic clustering of mutated strains further
shows a degree of variation by 29 nucleotide substitutions from the first wave of viral
strain from Wuhan city in China [74]. In comparison with the strain that constituted the
first wave from Wuhan city, the mutated variants have higher viral load, transmissibility of
70% and high receptor binding capacity to evade host immune response by altering the
surface structures recognised by antibodies from SARS-CoV-2.
Table 3. Nomenclature and description of mutated strains of COVID-19 identified and reported in 2020.
Coronavirus
Variants Brief Description of the Variants
COVID-19
Earliest viral lineage sharing nucleotide positions (8782 in ORF1ab and 28,144 in ORF8) with the closest species, i.e., bat
(BetaCov/Wuhan/WH01/2019) viruses (RaTG13 and RmYN02).
Genome sequence of early lineage (GenBank accession No. MN908947) similar to the phylogeny of SARS-CoV-2.
B.1.1.7
B.1.1.7, first called VUI 202012/01. It has 14 nonsynonymous amino acid altering mutations, 6 synonymous (non-AA-altering)
mutations, and 3 deletions (69/70 deletion, P681H, ORF8 stop codon (Q27stop)).
Mutates in the receptor-binding domain (RBD) of spike protein at position 501, where amino acid asparagine (N) is replaced
with tyrosine (Y).
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Table 3. Cont.
Coronavirus
Variants Brief Description of the Variants
N501Y
Mutation denotes a change from asparagine (N) to tyrosine (Y) in amino acid position 501. It binds to ACE2 receptors in
humans and spreads faster between people. Detected in the United Kingdom.
Variant 501.V2 has 10–20 mutations and spreads faster than the original SARS-CoV-2.
501.V2 was first detected in South Africa and increases binding of the virus to receptors in human cells.
D614G
Emerges from an ancestral D residue found in the glycosylated region of the viral spike protein.
G (glycine) replaces D (aspartic acid) in the RBD of spike glycoprotein to boost transmission rate of SARS-CoV-2 in China and
Italy. Loss of smell (anosmia) is linked with this variant.
B.1.1.7 deletions identified in spike protein; harbours a truncated ORF8 gene.
Y839 variant The spike Y839 variant is a descendant of G614 variant, the strongest trigger of the first wave of SARS-CoV-2 transmission inItaly and Portugal.
Nextstrain clade




It is a “variant of concern”, first identified in India, found to be 40–60% more transmissible than the α-variant of SARS-CoV-2.
Multiple spike protein mutations
Having protein mutations (deletion 69–70, deletion 144, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H) in various genomic regions and
mutations (N501Y) located within the receptor-binding domain.
Sources: [75–82].
Globally, coronavirus invasion and lethality are causing huge economic losses in the
livestock and meat industries, with emergency mass culling and excess mortalities of meat
species and fur producing mink in North America, Nordic countries and regions seriously
hit by the virus. Susceptibility to infectious diseases has been linked with the ABO blood
phenotypes [83]. The ABO blood group, in particular, plays a functional role in viral
infections. Intriguingly, patients with non-O blood group have a higher risk for COVID-19
infection when compared to O blood groups, and the ABO blood group can influence
coagulation factor VIII (FVIII) [84,85]. Blood type consists of antigenic factors of the red
blood cells which represent inherited polymorphic traits among individuals. The allelic
products of a given genetic locus are the blood group system. In other words, blood types
are inherited traits of the red blood cells (RBCs) termed positive (A+) or negative (A−)
and determined by polymorphic and antigenic components of the RBC membrane [86].
The presence or absence of species-specific antigenic molecules on the surface of red blood
cells (erythrocytes) determines the blood types. A, B, C, F, G, H, I, K, L and M are symbols
used for designation. When antigens exist as protein molecules or oligosaccharide sugars
above the cell surface, they induce immune-mediated reactions. While no disease results
from lack of expression of ABO blood group antigens, a number of illnesses may change
an individual’s ABO phenotype. Animal erythrocytes have cell surface antigens that go
through a polymorphic process and give rise to blood types. The systems are identified by
a letter: A, B, C, D, E, H, I, J, K, L, N, P and R. For instance, bovine species such as cattle
have 11 major blood group systems: A, B, C, F, J, L, M, R, S, T and Z. Avian species such as
domestic chickens have 13 alloantigen systems in the nucleated red blood cells and other
cell types. In the context of the coronavirus pandemic, sampling or validating blood types
of various avian and mammalian species, sequencing antigenic factors and correlating such
findings with herbivory and heritable susceptibility to COVID-19 infection is a knowledge
gap that has not been addressed to confirm susceptibility indices of various livestock
breeds exposed to different environmental dynamics. Again, apart from omics tools for
syndromic detection, there is no evidence of multiple pleiotropic expressions, multiplicity
of infection, autoimmune mechanisms and blood typing markers coding for susceptibility
to SARS-CoV-2 or its mutated strains across avian, bovine, ovine, porcine or semiaquatic
breeds and neonates. While seeking answers to these issues, using a triage colour-coding
system and modifying livestock stocking density (which is a way of mimicking social
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distancing in humans) for contact tracing of confirmed vs. probable cases among livestock
looks promising for determining positivity index in paddocks or poultry pens to raise
biosecurity and safeguard against viral outbreaks on livestock farms (Figures 3 and 4).
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4.2. Herd Immunity Versus Eco-Exposure to Viral Infections
Since December 2019 when the outbreak of COVID-19 was first reported in China, the
viral spread has not ceased to be an endemic despite the promotion of personal protection
equipment, self-isolation, social distancing, vaccination and other health surveillance strate-
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gies. Exposure to infections often elicits debilitating effects that impact general welfare
vis-a-vis a range of complex factors including genetic heritability, exposomics and phylody-
namics. Varying exposure levels to ambient conditions influencing viral infectivity across
species and mechanisms of action make it is tricky to identify disease reservoirs or fomites
where COVID-19 virions can be spotted. It is even a Herculean task to estimate the totality
of dietary and pathogenic exposures for free-range herbivores, by reason of variable dietary
preferences and underlying health conditions. To date, breaking the transmission chain or
obtaining relative protection of population groups from infectious agents is still a mirage
as the transmission of SARS-CoV-2 and its mutated strains are still traversing international
boundaries with cases of corona-storms and reinfection emerging. The overstretching of
primary healthcare facilities, disruption of normality in society and high mortality rate on
a scale that has never been witnessed make SARS-CoV-2 a deadly virus against humanity.
Ostensibly, the herd immunity threshold has not been reached for SARS-CoV-2 and its
mutant strains in many countries. This natural phenomenon occurs when a large propor-
tion of the pathogen-dependent population becomes immune to infection naturally or by
vaccination. The absence of exponential growth or decline in additional infections describes
this threshold point or endemic steady state in relation to antigenic drift or reassortment
of separate viral genome segments for initiating changes in the viral epitope [87]. While
disease eradication may not happen instantly, an overshoot can still occur. Assuming each
person in a homogeneous population is susceptible to endemic infections, herd immunity
threshold will be determined from effective reproduction number (Rn) and expressed as
RoS = 1, where Ro is “basic reproduction number of infection” and S is “truly susceptible
population or measure of contagiousness”. Further, S = (1 − p), where p is the proportion
of the immune population. Paul et al. [88] posit that if S equals reciprocal of Ro (i.e., 1/Ro),
the average number of transmissions per case (Rn) will be 1 and remain constant with
time (t).
4.3. Biosensing and Smart Precision Farming Models in COVID-19 Era
The conventional systems of arable farming and livestock husbandry still dominate
the current food system [89]. Of the 71% habitable land area, approximately 80% (40 mil-
lion km2) of terrestrial space used for animal agriculture encompasses different forms
of livestock ranching, stock keeping and pastoralism. In the context of highly polarised
views of animal products among vegans, vegetarians and meat consumers, the livestock
industry remains one of the main drivers of land-use dynamics, contributing to 25–50% of
agricultural gross domestic product. As the livestock density increases and becomes closely
intertwined with wildlife and humans, there is a growing concern about outbreaks of infec-
tious diseases, with 66% of the annual emerging ones being traceable to animal origins; such
outbreaks carry the potential of decreasing the production efficiency of livestock by almost
33%. Genomic evidence for SARS-CoV-2 suggests that it has a zoonotic source [32,90,91].
To proactively transform the livestock industry into a sustainable sector that conforms
with the new-normal realities in the COVID-19 era, integrating precision smart livestock
farming requires reliable networks of digital technologies and smart sensors for real-time
tracking of infectious diseases and animal welfare (Table 4). The livestock industry is under
immense pressure to curtail food insecurity by producing more by-products such as eggs,
meat, milk, wool and fur using precision agriculture, digital technologies and high-value
nutrient sources. With artificial intelligence, computer-based algorithms, cloud computing
and big data analytics, digital animal monitoring devices such as wearables are gaining
ground in cattle monitoring, enabling real-time information on individual cows.
Sustainability 2021, 13, 12381 19 of 27
Table 4. Selected viral genomes, serotypes, receptors and biosensors with applications in virology.
Biosensor Target Genome Influenza Serotype Bioreceptor
Impedimetric Single-stranded, negative-sense RNAvirus H5N1 panzootic in poultry (bird flu) Antibody
Impedimetric Virus H5N1 Aptamer
Impedimetric
Avian virus, roughly spherical (120
nM) and genome consisting of 8 RNA
fragments
H5N1: has haemagglutinin type 5
combined with neuraminidase type 1,
with glycoprotein spikes on the surface
encoding 10 proteins
Aptamer
Amperometric NA H1N1 (swine flu)H3N2 (human influenza-A)
4,7-Di-Ome
N-acetylneuraminic acid
Voltammetric Virus Influenza B DNA probe
Voltammetric Virus HPAIV H7N1 (Muscovy duckling flu) Antibody




lymphotropic virus with major CpG
island methylator phenotype
Epstein–Barr virus (EBV)
(human γ-herpesvirus 4) activates
retrovirus HERV-W/MSRV causing




Partly double-stranded circular DNA
virus with ~3.2 kbp that replicates by
a reverse transcriptase via an RNA
intermediate
Hepatitis B virus (HBV) encodes
4 overlapping open reading frames
(ORFs) (S, C, P and X) and infects
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AuNPs,
Impedance Negative-sense RNA viruses fromOrthomyxoviridae AIV H5N1 NH2-ssDNA probe
Impedance Virus Antibody Conductive polymer
Impedance Virus from Orthomyxoviridae H5N2 Magneticnanobeads/antibody
PPT, LSPR Virus from Coronavidae SARS-CoV and SARS-CoV-2 Gold nanoislands (AuNIs)
Sources: [91–110].
Whilst the rates of infection and mortality rates continue to soar with no permanent
solution to hasten herd immunity or eradicate the ill-fated coronavirus and its mutated
variants, the use of robotic drones powered with multianalyte biosensors is proposed for
eco-sensing and tracking of the natural reservoir of viral infections in livestock farms and
agro-processing units (Figure 4). Biosensors are analytical devices with receptors, transduc-
ers and detectors of measurable signals [92–111]. These devices allow multitarget analyses
and automation of analytes under in vivo or in vitro systems with the aid of receptors
(antibodies, whole cells, enzymes, nucleic acids or aptamers); transducers (semiconductor
or nanomaterial); and signal amplifiers, processors or display units for detection. The
use of biosensors makes it easy to measure antigen–antibody interactions momentarily
and allow accurate determination of binding kinetics and affinity constants. They have
multiple applications for detecting compounds by electrical, thermal or optical signals
in food, water and the environment [100,103]. Biosensors can be designed for real-time
monitoring of multiple parameters at each production step or multiple time points during
the automation of industrial facilities (Table 3). As a miniaturised device, a biomedical
micro-electromechanical system (Bio-MEMS), synonymous with lab-on-a-chip and micro
total analysis system (µTAS), is suitable for biological applications of molecular diagnos-
tics, point-of-care diagnostics, tissue engineering, single-cell analysis and implantable
microdevices. Agro-compatible, scalable, sensitive, specific, miniaturised, affordable and
user-friendly biosensors can potentially boost biosecurity measures in the livestock in-
dustry and food processing units. Identification of target analytes following selection of
suitable bioreceptors; transducer design that translates binding reaction into measurable
signal; miniaturisation for integration into lab-on-chip tools, automation for real-time anal-
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ysis, on-site testing or point-of-care detection; enhancement of sensitivity and linearity and
minimisation of interference; and configuration for efficient real-time sensing are the main
strengths of biosensors [100–109]. In addition to the use of biosensors for eco-sensing, their
use can be extended for tracking fomites or reservoirs of infections and multiparametric
measures for determining the welfare of livestock in the agro-environment (Table 5).
Table 5. Multiparametric measures for sensing lethality of coronavirus from putative organs, aerosols and animal by-
products.
Biosensing RNA Viruses for Organ Functionality in Animal and Domestic Avian Species
Target Organ Common Symptoms Biosensor
Lungs
Acute respiratory syndrome due to dyspnea or tachypnea that
provokes other symptoms found in respiratory infections, e.g.,
fever and cough. Gold nanoparticles (AuNPs) and quantum
dots for detecting viral respiratory syndrome
virusSevere infection can lead to pneumonia as the lung tissue fills
with fluid and pus, reducing the air sacs’ ability to transfer
oxygen into the blood
Heart
Acute coronary syndrome, congestive heart failure,
arrhythmias causing inflammation of heart muscle or
myocarditis, abnormal rhythms, progressive heart failure,
sudden cardiac death
Wearable viral trackers
Brain/nervous vessels Blood clotting, nerve damage or burst vessels in the brain, e.g.,dementia-like syndrome, delirium, stroke and seizures Real-time lab-on-chip (LOC), point-of-care
(POC) pathogen detecting sensorsDisruption of brain signalling, temporary loss of smell
(anosmia)/taste, depression
Gastrointestinal system General malaise, bowel abnormalities, acute pancreatitis,sudden inflammation
Enzymatic biosensors (enzyme–target analyte
interaction), whole-cell biosensor
Body temperature Pyrexia/pyrogen Wearable fitness trackers
Blood vessels
Destruction of endothelial cells or cytokine storm; constriction
of blood vessels, leaky vessel walls, pulmonary embolism,
hypercoagulability and low oxygen levels in blood
Immunosensors (antibody–antigen interaction)
Kidney Cytokine storm can trigger kidney failure or systemicabnormalities in the renal system
Biosensor (AuNPs) for detecting creatinine
levels in kidney healthy states and disease
progression
Abnormally high levels of liver enzymes, indicating at least
temporary damage
Biosensing RNA viruses in aerosols and animal by-products and agri-environment
Livestock feeds, water, saliva,
urine, sweat, tears
Noninvasive, miniaturised POC sensor for real-time monitoring, wearable microfluidic multisensory biosensors,
electrochemical sweat biosensors
Meat/meat products Lab-on-a-chip (LOC) wearable biosensor analysis and intracellular analysis in a miniaturised multifunctional chip
with real-time, noninvasive, and nonirritating sensing capacities for cell sorting, single-cell capture and
captured-cell transport; lipid-based nanosystem; liposome containing siRNA nanoparticlesMilk/dairy products
Aerosols/air quality Telemetry wearable microfluidic for sensing air quality; portable mouth-guard biosensor, micro total analysissystems (µTAS), optical RNA sensor for sampling aerosolised pathogens, aerodynamic particle spectrometer
Fur, hide and skin Epidermal potentiometric sensor, wearable skin-interfaced analytics body sensor
As the security of animal products largely depends on eco-exposure to several vari-
ables where open grazing occurs, the choice of biosensor is based on its comparative ad-
vantage over conventional diagnostic assays for detecting nanosized virions on-farm and
along food production supply chains. Precision livestock farming (PLF) is one of the novel
technologies with broad spectra of applications. Agriculturists in developed nations adopt
PLF principles to provide accurate information for daily operations, real-time monitoring of
animal welfare and fast interventions for optimising farm management systems. Different
biosensors are used in PLF in the form of eating/grazing sensors for eating, ruminating,
resting and active behaviours (Agis Automatisering SensOor); neck-mounted sensors for
monitoring grazing and animal position; eating sensor validation; collar-mounted sensors;
and rumen sensors. Within livestock sectors, the PLF is smartly designed to monitor
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microclimate or agro-environment and routinely record feed utilisation, flock performance
and general welfare. Landscape tracking of livestock and occupancy-based monitoring
among other livestock precision farming smart technologies are advantageous in the live-
stock industry for improving farm labour efficiency, record-keeping and real-time decision
making about routine and periodic activities. Other things to sense include the livestock
storage tanks, silos, paddocks, poultry pens, milking parlours, feeds, chewing period, feed-
ing equipment, milking equipment, feeding behaviour, water, critical transition periods
(pregnancy, gestation, lactation cycle, incubation period), body temperature, rumination,
pH, methane emission, spirometry indices, oestrus cycles and carbon footprints. Innova-
tive wearable sensors can be developed to monitor animal welfare, detect the presence
of infectious disease and monitor physiological parameters to allow rapid confirmatory
diagnosis of suspected cases. The equations below in Figure 5 can be applied in integrated
monitoring of exposure dynamics and transmission of SARS-CoV-2 variants.
dS
dt








− β2E− µE (3)
dI
dt
= β2E + β5Q− β3 I − β4 I − (µ + α)I (4)
dQ
dt
= β4 I − β5Q− β6Q− (µ + α)Q (5)
dR
dt
= β3 I + β6Q− µR (6)
N(total population) = S (t) + E (t) + I (t) + Q (t) + R (t)
with the initial condition (S(0), E(0), I(0), Q(0), R(0)) = (S0, E0, I0, Q0, R0).
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Figure 5. On-farm compartmental model for exposure dynamics and transmission of SARS-
CoV-2 variants.
As shown above (Figure 5), the modified SEIR compartmental mathematical model,
which we could call the SEIQR model for exposure dynamics and transmission of SARS-
CoV-2 variants, implies that any animal in a population belongs to one of five states:
susceptible (S), exposed (E), infectious (I), quarantine (Q) and recovered (R). The animals
in the susceptible states are assumed to be healthy but have no immunity against the
virus, and thus they can contract the virus at any time. The animals in the exposed state
are vulnerable to the virus. The infected ones can harbour and transmit the virus to any
organism they come in contact with. Any animal that is infected either recovers naturally
from the disease or will be moved to the quarantine state. Some animals can also recover
from the quarantine state. It is assumed that a recovered animal has a low (but not zero)
chance of reinfection. The susceptible animals move to the exposed compartment (E) at a
rate β1 (I/N). Animals in the exposed compartment move to the infectious compartment
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(I) at a rate β2. Natural death occurs at a rate µ in all the five compartments. The rate of
death due to COVID-19 is α. The rate of recovery (R) for infectious animals is β3. The
rates at which the infectious animals enter the quarantine compartment (Q) and return
to the infectious compartment are β4 and β5, respectively. The compartmental model
culminates in a five-dimensional system of ordinary differential equations (ODEs) as seen
in Equations (2)–(6). Figure 6 shows the drone powered by biosensors and radio modem
system to provide daily data on animal welfare including the Ultra high frequency (UHF)
receiver that uses radio waves, the robot which contains an accelerometer sensor and
GPS system network. This is an automatic system that responds to ambient temperature
fluctuations and triggers at a threshold with an accurate precision of location of grazing
livestock and time. The cloud provides a petabyte of data processing and storage sys-
tem. The output is decision-based information that is available in real time. The entire
system can be effectively utilized for biosensing the outbreak of infectious diseases in
livestock industry.
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effects of these infections will be in the nearest future. Another worrisome issue for
the livestock sector is the potential of a wide range of mammalian and avian species
being natural reservoirs for different strains of infectious zoonotic diseases such as coro-
navirus with its highly transmissible variants. Knowing that herd immunity is not yet
attained in many climes and that livelihood partly depends on food security from animal
products, indiscriminate exposure of farmers and livestock during routine and periodic
activities to environmental variables harbouring coronaviruses may pose a serious threat
to public health and food production. Thus, neglecting the impacts of viral aerosols
on agrarian communities will unavoidably have devastating effects on animal welfare
and food security. Therefore, effective use of smart precision livestock models, biosensor-
powered digital technology and Internet of Things (IoT) may enhance catch-all and efficient
monoplex or multiplex platforms for rapid-response and high-throughput screening of
livestock and the agro-environment to limit transmissibility of zoonotic infections along
food chains. A combination of digitalised technologies can be introduced into communal
farming systems and rebranded with a modernised sense of “cooperative smart livestock
farming” to help the resource-poor farmers mitigate transitioning into the new-normal
realities in the livestock industry for realising sustainable and high production efficiency of
animal products.
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